secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296630
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phathom amends bylaws to adopt universal proxy rules and enhance stockholder nomination disclosures
--------------------------------------------------------------------------------

- Amended bylaws require compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.
- Enhanced disclosure requirements for stockholders nominating directors or submitting proposals at meetings.
- Changes effective December 13, 2023; also includes technical and modernizing updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312523296630/0001193125-23-296630-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312523296630/d602391d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296630

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer